---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-005292"
form_type: "8-K"
ticker: "CPRX"
cik: "0001369568"
company_name: "CATALYST PHARMACEUTICALS, INC."
filed_at: "2024-01-09T23:59:59+00:00"
generated_at: "2026-06-07T01:24:21.615160+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Catalyst Pharmaceuticals closes $150M public offering of 10M shares at $15; net proceeds ~$140.1M

## Summary
- Sold 10,000,000 shares of common stock at $15.00 per share in an underwritten public offering.
- Net proceeds after underwriting discounts and estimated expenses were approximately $140.1 million.
- Underwriters granted a 30-day option to purchase up to an additional 1,500,000 shares.
- Proceeds to be used for potential acquisition of new product candidates and general corporate purposes.
- Bookrunners: BofA Securities, Citigroup, Piper Sandler, Cantor, Truist Securities.

## SEC filing metadata
- accession: 0001193125-24-005292
- form_type: 8-K
- ticker: CPRX
- cik: 0001369568
- company_name: CATALYST PHARMACEUTICALS, INC.
- filed_at: 2024-01-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1369568/000119312524005292/0001193125-24-005292-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1369568/000119312524005292/d702064d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-005292
- JSON: https://secwatch.observer/filing/0001193125-24-005292.json
- Plain text: https://secwatch.observer/filing/0001193125-24-005292.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.